Agilent | A - Fremdkapital

Aktienkurs
110.57
Täglich Wechseln
-1.54 -1.37%
Monatlich
-8.59%
Jährlich
-2.56%
Q2 Prognose
109.45




Fremdkapital Veränderung Datum
Abbott USD 29.64B 19.74B 2026-03
Agilent USD 3.05B 0 2025-12
Align Technology USD 0 0 2024-12
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 802.9M 398.8M 2026-03
Bruker USD 1.66B 189.6M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.01B 9M 2026-03
Edwards Lifesciences USD 600M 1.7M 2026-03
Henry Schein USD 2.33B 17M 2026-03
Illumina USD 1.49B 0 2026-03
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 13.99B 105M 2026-03
Laboratory Of America USD 5.9B 748.3M 2026-03
Mettler Toledo International USD 2.16B 73.35M 2026-03
Myriad Genetics USD 120.3M 400K 2026-03
OraSure Technologies USD 100K 17K 2025-12
Quest Diagnostics USD 5.16B 12M 2026-03
Quidel USD 0 2.47B 2026-03
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 2.63B 836K 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Waters USD 5.22B 3.81B 2026-03
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03